1. Home
  2. AXGN vs DLX Comparison

AXGN vs DLX Comparison

Compare AXGN & DLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXGN
  • DLX
  • Stock Information
  • Founded
  • AXGN N/A
  • DLX 1915
  • Country
  • AXGN United States
  • DLX United States
  • Employees
  • AXGN N/A
  • DLX N/A
  • Industry
  • AXGN Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • DLX Advertising
  • Sector
  • AXGN Health Care
  • DLX Consumer Discretionary
  • Exchange
  • AXGN Nasdaq
  • DLX Nasdaq
  • Market Cap
  • AXGN 804.8M
  • DLX 867.6M
  • IPO Year
  • AXGN N/A
  • DLX N/A
  • Fundamental
  • Price
  • AXGN $22.68
  • DLX $18.17
  • Analyst Decision
  • AXGN Strong Buy
  • DLX Strong Buy
  • Analyst Count
  • AXGN 7
  • DLX 1
  • Target Price
  • AXGN $27.71
  • DLX $23.00
  • AVG Volume (30 Days)
  • AXGN 879.1K
  • DLX 226.5K
  • Earning Date
  • AXGN 10-29-2025
  • DLX 11-05-2025
  • Dividend Yield
  • AXGN N/A
  • DLX 6.55%
  • EPS Growth
  • AXGN N/A
  • DLX 49.73
  • EPS
  • AXGN N/A
  • DLX 1.28
  • Revenue
  • AXGN $214,709,000.00
  • DLX $2,106,724,000.00
  • Revenue This Year
  • AXGN $19.63
  • DLX $0.20
  • Revenue Next Year
  • AXGN $15.83
  • DLX $1.65
  • P/E Ratio
  • AXGN N/A
  • DLX $14.15
  • Revenue Growth
  • AXGN 18.72
  • DLX N/A
  • 52 Week Low
  • AXGN $9.22
  • DLX $13.61
  • 52 Week High
  • AXGN $23.14
  • DLX $24.45
  • Technical
  • Relative Strength Index (RSI)
  • AXGN 81.49
  • DLX 41.64
  • Support Level
  • AXGN $17.14
  • DLX $17.82
  • Resistance Level
  • AXGN $18.34
  • DLX $19.52
  • Average True Range (ATR)
  • AXGN 0.97
  • DLX 0.47
  • MACD
  • AXGN 0.55
  • DLX -0.01
  • Stochastic Oscillator
  • AXGN 94.15
  • DLX 20.59

About AXGN Axogen Inc.

Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.

About DLX Deluxe Corporation

Deluxe Corporation is principally a payments and data company. Its reportable segments are; Merchant Services, B2B Payments, Data Solutions, and Print. Maximum revenue is derived from its Print segment which provides printed personal and business checks, business essentials, as well as branded promotional, print, apparel, and digital storefront solutions. The Merchant Services segment provides electronic credit and debit card authorization, payment systems, and processing services. The B2B segment offers treasury management solutions, integrated accounts payable disbursements, and fraud and security services, and the Data Solutions segment offers data, analytics, and marketing services as well as financial institution profitability reporting and business incorporation services.

Share on Social Networks: